Cornes Michael P, Church Stephen, van Dongen-Lases Edmée, Grankvist Kjell, Guimarães João T, Ibarz Mercedes, Kovalevskaya Svetlana, Kristensen Gunn Bb, Lippi Giuseppe, Nybo Mads, Sprongl Ludek, Sumarac Zorica, Simundic Ana-Maria
Departments of Clinical Chemistry, New Cross Hospital, Wolverhampton, West Midlands, UK
BD Life Sciences - Preanalytical Systems, Oxford, UK.
Ann Clin Biochem. 2016 Sep;53(Pt 5):539-47. doi: 10.1177/0004563216643969. Epub 2016 May 1.
Patient safety is a leading challenge in healthcare and from the laboratory perspective it is now well established that preanalytical errors are the major contributor to the overall rate of diagnostic and therapeutic errors. To address this, the European Federation of Clinical Chemistry and Laboratory Medicine Working Group for Preanalytical Phase (EFLM WG-PRE) was established to lead in standardization and harmonization of preanalytical policies and practices at a European level. One of the key activities of the WG-PRE is the organization of the biennial EFLM-BD conference on the preanalytical phase to provide a forum for National Societies (NS) to discuss their issues. Since 2012, a year after the first Preanalytical phase conference, there has been a rapid growth in the number of NS with a working group engaged in preanalytical phase activities and there are now at least 19 countries that have one. As a result of discussions with NS at the third conference held in March 2015 five key areas were identified as requiring harmonisation. These were test ordering, sample transport and storage, patient preparation, sampling procedures and management of unsuitable specimens. The article below summarises the work that has and will be done in these areas. The goal of this initiative is to ensure the EFLM WG-PRE produces work that meets the needs of the European laboratory medicine community. Progress made in the identified areas will be updated at the next preanalytical phase conference and show that we have produced guidance that has enhanced standardisation in the preanalytical phase and improved patient safety throughout Europe.
患者安全是医疗保健领域的一项主要挑战，从实验室角度来看，现已明确，分析前误差是诊断和治疗误差总体发生率的主要促成因素。为解决这一问题，欧洲临床化学和检验医学联合会分析前阶段工作组（EFLM WG-PRE）成立，以在欧洲层面牵头开展分析前政策和实践的标准化与协调工作。WG-PRE的关键活动之一是每两年组织一次关于分析前阶段的EFLM-BD会议，为各国学会（NS）提供一个讨论其问题的平台。自2012年，即第一届分析前阶段会议召开一年后，参与分析前阶段活动的工作组所在的NS数量迅速增长，目前至少有19个国家设有这样的工作组。在2015年3月举行的第三届会议上与NS进行讨论后，确定了五个需要协调的关键领域。这些领域是检验医嘱、样本运输和储存、患者准备、采样程序以及不合格样本的管理。以下文章总结了在这些领域已经开展和将要开展的工作。该倡议的目标是确保EFLM WG-PRE开展的工作能够满足欧洲检验医学领域的需求。在确定领域所取得的进展将在下一届分析前阶段会议上更新，并表明我们已经制定了相关指南，增强了分析前阶段的标准化，并提高了全欧洲的患者安全。
